324 related articles for article (PubMed ID: 17009941)
21. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
Ndowa F; Lusti-Narasimhan M; Unemo M
Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629
[No Abstract] [Full Text] [Related]
22. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.
Martin IM; Hoffmann S; Ison CA;
J Antimicrob Chemother; 2006 Sep; 58(3):587-93. PubMed ID: 16816397
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
Chan DJ; Tapsall J
Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
[TBL] [Abstract][Full Text] [Related]
24. [Materials on the study of antibiotic sensitivity of gonococci].
Tadzhibaev TT; Soina KK; Desiatchikova AV; Sinitsina LM; Bochkova EA
Urol Nefrol (Mosk); 1975; (2):45-7. PubMed ID: 804199
[No Abstract] [Full Text] [Related]
25. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
[TBL] [Abstract][Full Text] [Related]
26. [Further increase of quinolone resistance of gonococci in the Netherlands and proposal for a new surveillance].
Koedijk FD; Borgen K; van Loo IH; van de Laar MJ
Ned Tijdschr Geneeskd; 2007 Jan; 151(2):142-3. PubMed ID: 17315494
[TBL] [Abstract][Full Text] [Related]
27. One-step PCR for the identification of multiple antimicrobial resistance in Neisseria gonorrhoeae.
Lawung R; Cherdtrakulkiat R; Charoenwatanachokchai A; Nabu S; Suksaluk W; Prachayasittikul V
J Microbiol Methods; 2009 Jun; 77(3):323-5. PubMed ID: 19341768
[TBL] [Abstract][Full Text] [Related]
28. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
De Jongh M; Dangor Y; Adam A; Hoosen AA
Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique.
Apalata T; Zimba TF; Sturm WA; Moodley P
Sex Transm Dis; 2009 Jun; 36(6):341-3. PubMed ID: 19556927
[TBL] [Abstract][Full Text] [Related]
30. Is gonorrhea becoming untreatable?
Blomquist PB; Miari VF; Biddulph JP; Charalambous BM
Future Microbiol; 2014; 9(2):189-201. PubMed ID: 24571073
[TBL] [Abstract][Full Text] [Related]
31. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1999. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.
Commun Dis Intell; 2000 Sep; 24(9):269-71. PubMed ID: 11089306
[TBL] [Abstract][Full Text] [Related]
32. Detection, management and control of antibiotic resistant strains of Neisseria gonorrhoeae.
Iowa Med; 1987 Sep; 77(9):461-2. PubMed ID: 3117722
[No Abstract] [Full Text] [Related]
33. Mitigating the emergence and spread of multidrug- and extensively drug-resistant gonorrhea: is there sufficient support in resource-poor settings in Africa?
Unemo M; Dillon JA
Sex Transm Dis; 2014 Apr; 41(4):238-9. PubMed ID: 24622634
[No Abstract] [Full Text] [Related]
34. [The role of the variability of gonococci in the development of therapeutic-prophylactic measures in gonorrhea].
Mavrov II; Gorisiuk AF
Mikrobiol Zh (1978); 1987; 49(4):62-4. PubMed ID: 3150499
[No Abstract] [Full Text] [Related]
35. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial.
Unemo M; Shipitsyna E; Domeika M;
Sex Transm Infect; 2010 Nov; 86(6):442-4. PubMed ID: 20460266
[TBL] [Abstract][Full Text] [Related]
36. Genotypes and antimicrobial-resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004-2009).
Florindo C; Pereira R; Boura M; Nunes B; Paulino A; Gomes JP; Borrego MJ
Sex Transm Infect; 2010 Nov; 86(6):449-53. PubMed ID: 20940158
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic resistant gonococci.
Br Med J; 1971 Dec; 4(5789):696-7. PubMed ID: 5001989
[No Abstract] [Full Text] [Related]
38. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
Tuddenham S; Ghanem KG
Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
[No Abstract] [Full Text] [Related]
39. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.
Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC
Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963
[TBL] [Abstract][Full Text] [Related]
40. The use of cephalosporins for gonorrhea: the impending problem of resistance.
Barry PM; Klausner JD
Expert Opin Pharmacother; 2009 Mar; 10(4):555-77. PubMed ID: 19284360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
